Both qualitative and quantitative virologic measurements were compared between blood and genital compartments for 128 men infected with human immunodeficiency virus type 1 (HIV-1) to address several controversial issues concerning HIV-1 shedding in semen and to obtain further information about the distribution of virus between these two compartments. Evidence for viral compartmentalization was suggested by earlier studies that noted the poor correlation between blood and seminal virus load, phenotype, and genotype. Further support for this viral compartmentalization was based on the following observations between semen and blood: lack of association between culturability of virus in semen and viral RNA level in blood, discordant distribution of viral phenotypes, discordant viral RNA levels, a weak correlation between viral RNA level in semen and CD4 cell count in blood, differences in the biologic variability of viral RNA levels, and differences in the virus load response to antiretroviral therapy.
Worldwide, sexual contact is the most common mode of such as cocultivation, electron microscopy, and molecular methods, to detect and quantify seminal levels of HIV-1 [4 -human immunodeficiency virus type 1 (HIV-1) transmission, and semen is the body fluid responsible for most instances of 9, 13 -18] . These studies reported a number of contradictory findings, including intermittent HIV-1 shedding, varying culthis transmission [1] . However, relatively little is known about the biology of HIV-1 within the male genital tract or the factors ture-positivity rates, and discrepancies between detection of virus by use of mixed lymphocyte coculture or polymerase that determine either levels of virus expression and infectiousness of semen or the variation in these levels over time chain reaction (PCR) amplification methods. We investigated the relationship between the HIV-1 RNA [2, 3] . HIV-1 nucleic acid (DNA or RNA) is detected in most semen specimens from infected men, but infectious virus is level in seminal plasma and presence of infectious virus in seminal cells and plasma and compared the variation over time detected by coculture in fewer than half of specimens [4 -10] . Because the male reproductive tract is a distinct immunologic in HIV-1 RNA levels in seminal and blood plasma. Defining these virus parameters would provide insight into the biologic compartment, the factors determining infectiousness of semen may differ substantially from the factors determining HIV-1 factors responsible for the sexual transmission of HIV-1. Clinically, this information is important for epidemiologic studies, levels in the blood, lymphatic tissue, or central nervous system [2, 7, 11, 12] . Previous studies used a variety of techniques, the design of therapeutic trials, and, possibly, reproductive management.
4-week intervals and to remain sexually abstinent for 2 days before 10 logarithms to normalize the data and equalize the variances across the different concentrations of viral RNA. In all analyses providing each specimen.
Semen processing. Specimens were collected by masturbation except the random-effects models (see below), censoring of RT-PCR amplification values (õ400 RNA copies/mL of seminal at each subject's home, then transported to the laboratory within 3.5 h for semen analyses (mean time { SD, 72 { 40 min; range, plasma) and bDNA values (õ10,000 RNA copies/mL of blood plasma) was handled by assigning the values of one-half of the 20-210). Semen was diluted 1:1 with culture medium to reduce the viscosity before separation of the seminal plasma and seminal cutoff value, that is, 200 (2.30 log) RNA copies/mL and 5000 RNA (3.70 log) copies/mL, respectively. The Mann-Whitney U cell pellet by centrifugation at 2940 g for 2-4 min [5] . An aliquot of diluted seminal plasma was stored at 070ЊC for batched HIVtest, Wilcoxon signed rank test, Kolmogorov-Smirnov test, or Kruskal-Wallis test was used to assess potential associations of 1 RNA analysis, and if sufficient specimen was available, each fraction was cocultured separately for HIV-1 [5] .
seminal HIV-1 RNA levels with categorical variables such as study visit or recovery of virus by coculture. Associations between inde-HIV-1 RNA quantitation in seminal plasma. A reverse transcription (RT)-PCR amplification assay was used to quantify pendent categorical variables were assessed by the x 2 or Fisher's exact tests. Pearson product-moment correlation coefficients were HIV-1 RNA in the cell-free seminal plasma (Amplicor HIV Monitor; Roche Molecular Systems, Branchburg, NJ) [19, 20] . Previous used to assess trends in continuous data, Spearman rank correlation coefficients for ordinal data, and Kendall correlation coefficients experiments had shown that some seminal plasma specimens inhibited amplification of the internal quantitative assay standard. To for ordinal data from multiple independent variables such as antiretroviral therapy and HIV-1 coculture. evaluate the possible presence of an inhibitor, 1 of 2 aliquots from each specimen was pretreated with silica gel (Sigma, St. Louis)
A random-effects model was used to estimate the variance components in the semen and blood (after controlling for therapy) and to extract the HIV-1 RNA and remove the putative inhibitor before RT-PCR amplification [21] . Because of the dilution factor before to establish the confidence intervals for the expected variation in HIV-1 RNA levels over the 2 months of observation. To account the first centrifugation step, the assay sensitivity was 400 RNA copies/mL of seminal plasma. The HIV-1 RNA copy number per for the ''left-censoring'' of HIV-1 RNA levels in seminal and blood plasma, an adaptation of the method described by Pettit was milliliter was reported for undiluted seminal plasma.
HIV-1 cocultivation and MT-2 tropism in semen. Our method used [26] . The person-to-person and within-person variances were used to calculate the sample size for a two-arm randomized control for qualitative HIV-1 coculture is reported elsewhere [5] . The seminal plasma was filtered (0.45 mm), and the seminal cells were trial to detect 5-fold differences in seminal and blood plasma HIV-1 RNA levels due to a hypothetical treatment with 80% power suspended in 2.0 mL of culture medium. Cellular and plasma fractions were cocultured separately with 10 1 10 6 3-to 4-dayand a two-tailed a Å .05 [27] . A random effects model that controlled for the repeated measures on individual men was used to old phytohemagglutinin (PHA)-stimulated donor cells in 15 mL of medium containing 5% nonrecombinant human interleukin-2 derive the P for the association between viral RNA level and recovery of virus by qualitative coculture and also the effect of (Pharmacia, Piscataway, NJ). One-half of the culture medium was exchanged twice each week, and cultures were replenished with antiretroviral therapy and blood CD4 cell count on viral RNA level in both semen and blood. 3 1 10 6 new PHA-stimulated donor cells every 7 days for 28 days. HIV-1 production was assessed weekly by demonstrating a sustained HIV-1 p24 antigen increase to ú30 pg/mL of culture Results medium (Abbott Laboratories, Abbott Park, IL). The syncytiuminducing (SI) or non-syncytium-inducing (NSI) phenotype of each Subjects. Baseline characteristics for the cohort are sumvirus isolate was assessed by inoculating 50 mL of an unfrozen, marized in table 1. A total of 161 men were screened for infected culture supernatant into duplicate microwells containing the study. Of these, 12 (7.5%) were lost to follow-up before 50 ,000 MT-2 cells [22, 23] .
providing their first specimen. Of the remaining 149 subjects, signs or symptoms of urethritis during the study. To minimize CD4 cell counts were determined by standard flow cytometric methods [24] . Blood plasma was stored at 070ЊC for batched selection bias, the analyses were restricted to the 128 men who HIV-1 RNA analyses.
completed all three study visits. Twelve (9.4%) of these men RNA from 3 to 6 log copies/mL were used, the measured viral Antiretroviral (nucleoside) use at entry None 63
RNA levels in seminal plasma were Ç2.5-fold higher by the was 4.436 (4.0 -5.967) log copies/mL by use of the bDNA assay. HIV-1 RNA was detected at §10,000 (or 4.0 log) copies/ mL of blood plasma in 251 (74.3%) of 338 specimens for which the median (range) HIV-1 RNA level was 4.627 (4.017 -inhibited in 149 (41.4%) of 360 available specimens across the full range of HIV-1 RNA levels (data not shown). Of these 5.967) log copies/mL. HIV-1 RNA variation in seminal and blood plasma. The 149 inhibited specimens, 127 (85.2%) had sufficient volumes to permit pretreatment with silica gel to remove the putative within-person variation for HIV-1 RNA level in either seminal or blood plasma was determined by plotting the difference inhibitor and to be reassayed, thus giving a total of 338 evaluable specimens with amplification of the internal quantitative between versus the average of the viral RNA measurements for the first and second visits (figure 1). The relationship bestandard. Of 128 men, 104 (81.3%) had each of their 3 semen specimens assessed for HIV-1 RNA without silica gel extractween the two variables was not significant for either semen or blood (P Å .73 vs. P Å .51), and the median differences tion of the viral RNA before RT-PCR amplification. The semen from 17 (16.3%) of these men consistently inhibited the internal were centered around zero, indicating stability of viral RNA variability over the range of viral RNA concentrations. The assay standard, the semen from 29 (27.9%) men inhibited inconsistently, and the semen from the remaining 58 (55.8%) within-person viral RNA variation (SD) was 0.812 log copies/ mL of seminal plasma versus 0.368 log copies/mL of blood men never inhibited the internal quantitative assay standard. For untreated semen specimens with amplification of the interplasma. We expected these values to underestimate the true variation because of the left-censoring that artificially reduced nal quantitative assay standard, silica gel extraction did not affect the quantitation of HIV-1 RNA (data not shown).
differences associated with viral RNA measurement near the lower boundary of detection for each assay. This effect acThe median (range) HIV-1 RNA level was 3.189 (2.602 -7.205) log copies/mL for 338 seminal plasma specimens from counted for the arrowhead shape in the difference plots. Therefore, we used random effects modeling (see Materials and 128 men. HIV-1 RNA was detected at §400 (or 2.602 log) copies/mL of seminal plasma in 204 (60.4%) of 338 semen Methods), controlling for antiretroviral therapy, to account for / 9d3f$$fe38 12-05-97 11:32:37 jinfa UC: J Infect respectively. These numbers are consistent with the observed values (based on the first two measurements only) of 0.812 log copies/mL of seminal plasma and 0.368 log copies/mL of blood plasma.
The expected within-person variation in seminal and blood plasma, after controlling for therapy, is shown in table 2. To show the utility of these variation measures for assessing the effect of a hypothetical therapy on HIV-1 RNA level, we determined the sample size required to detect a 5-fold treatment difference in either seminal or blood plasma HIV-1 RNA levels (table 3). Table 3 . Sample size calculations for hypothetical, 2-arm, randomof seminal plasma HIV-1 RNA level for 106 men. Mean HIV-1 RNA ized, controlled treatment trial designed to detect 5-fold difference in difference between visits was 0.086 log copies/mL (SD, 0.812). B, seminal or blood plasma HIV-1 RNA levels, with 80% power and 2-Within-person comparison of blood plasma HIV-1 RNA level for 116 tailed a Å .05. men. Mean HIV-1 RNA difference between visits was 00.013 log copies/mL (SD, 0.368). vidual subjects, which was necessary to ascertain the person- plasma from 128 men). The person-to-person HIV-1 RNA variation (SD) was 1.20
log copies/mL of seminal plasma and 0.58 log copies/mL of in figure 1 should be 1.14 log copies and 0.35 log copies/mL, For the 82 subjects with both coculture and seminal plasma pellet and plasma and 220 specimens were concordant for no recovery of virus. Because of limited specimen volumes, 87
HIV-1 RNA results at the first study visit, 8 (88.9%) of 9 coculture-positive men and 44 (60.3%) of 73 coculture-nega-(25.7%) of 338 specimens were assessed only for HIV-1 RNA copy number. The distribution of HIV-1 RNA copy numbers tive men had HIV-1 RNA detected in their seminal plasma (Fisher's exact test, P Å .14). The recovery of HIV-1 from for the specimens without coculture was similar to the distribution of HIV-1 RNA copy numbers for the 251 semen specimens semen by coculture at study entry was associated with the seminal plasma HIV-1 RNA level (Kolmogorov-Smirnov test, submitted for coculture (data not shown).
HIV-1 was cocultured from the seminal cell pellet or plasma P Å .025). To investigate this association further, the seminal plasma HIV-1 RNA levels for 232 specimens from 113 men once from 17 (14.8%) of 115 men with 1 or more cultures, twice from 3 (5.6%) of 54 men with 2 cultures each, and three with matching viral coculture results were divided into deciles for the coculture-positive and -negative specimens. Only 1 times from 2 (4.9%) of 41 men who had 3 cultures each. The median HIV-1 RNA level in seminal plasma was significantly (4.2%) of 24 coculture-positive specimens was associated with a seminal plasma HIV-1 RNA level õ2.80 log RNA copies/ greater for culture-positive compared with culture-negative semen specimens (figure 2). At the first study visit, 10 men were mL. Ten (71.4%) of 14 specimens with a seminal plasma HIV-1 RNA level ú5.30 log RNA copies/mL and 8 (88.9%) of 9 HIV-1 coculture -positive from either the seminal cell pellet (9 men) or plasma (1 man), and 73 men were negative; the specimens with ú5.80 log RNA copies/mL were coculturepositive. corresponding median (interquartile range) HIV-1 RNA log copies/mL of seminal plasma were 5.315 (4.121 -6.06) and MT-2 cell tropism was determined for 25 of 27 virus isolates from semen. Twenty-one isolates were from the seminal cell 3.144 (2.301 -3.749), respectively (Mann-Whitney U test, P õ .001).
pellet from 16 men and 4 isolates were from the seminal plasma of 3 men, 2 of whom also had virus isolated from the seminal cell pellet. For the seminal cell pellet fractions, 7 (33%) contained SI and 14 (67%) contained NSI isolates. For the 4 virus isolates from seminal plasma, 2 were SI and 2 were NSI phenotypes, and the phenotypes were concordant for seminal cell pellet -and plasma-associated virus. For 22 seminal virus isolates, the corresponding virus from PBMC was also characterized for SI or NSI phenotype. The viral phenotypes from semen and blood were concordant for 16, or 73% (4 SI and 12 NSI), and discordant for 6, or 27% (3 SI and 3 NSI). The seminal plasma HIV-1 RNA levels (median and interquartile range) were not different for either SI (n Å 7; 6.060 [3.893 -6 .237] log copies/mL) or NSI (n Å 13; 5.176 [4.130 -5.995] log copies/mL) phenotypes (Mann-Whitney U test, P Å .78). A similar result was observed for the blood-derived HIV-1 RNA levels and virus phenotype (data not shown). . Left-censored branched-chain DNA-derived values for blood plasma HIV-1 RNA (õ10,000 copies/mL) were assigned value of 5000 copies/mL (3.70 log) and reverse transcription -polymerase chain reaction amplification -derived values for seminal plasma (õ400 copies/mL) were assigned value of 200 copies/mL (2.30 log) for analysis.
contrasted with the stronger inverse correlation between CD4 less than monotherapy (00.39 log; P Å .18). The therapy comparisons for blood plasma HIV-1 RNA levels were as folcell count and blood plasma HIV-1 RNA level (Spearman rank correlation coefficient, r Å 0.447; P õ .001). In contrast to lows: monotherapy greater than no therapy (0.12 log; P Å .10); combination therapy less than no therapy (00.13 log; P Å .26); the seminal plasma HIV-1 RNA level, the recovery of HIV-1 from the semen by coculture was not associated with either combination therapy less than monotherapy (00.25 log; P Å .023). HIV-1 was cultured from the seminal cell pellet at the the blood plasma HIV-1 RNA level or the CD4 cell count (Kolmogorov-Smirnov test, P Å .56 and P Å .39, respectively). first study visit from 7 (11.7%) of 60 subjects who received no therapy, 2 (9.5%) of 21 subjects who received monotherapy, Effect of antiretroviral therapy. There was a trend for men who reported receiving combination antiretroviral therapy at and none of 7 subjects who received combination therapy (x 2 , P Å .62). The mean CD4 cell counts per microliter for evaluable the first visit to have lower HIV-1 RNA levels in their seminal plasma but not in blood plasma (figure 4). The random-effects subjects in each therapy group at the first study visit were as follows: no therapy, 389 (SD, 260; n Å 64); monotherapy, 302 model was used to evaluate the treatment effect for all 338 paired specimens of semen and blood. The therapy comparisons (SD, 199; n Å 24); and combination therapy, 286 (SD, 125; n Å 7) (Kendall correlation coefficient, t 01.677; P Å .094). for seminal plasma HIV-1 RNA levels (mean difference RNA log copies per milliliter) were as follows: monotherapy less A multivariate analysis using the random effects model was done to assess the independent effects of therapy and CD4 cell than no therapy (00.18 log; P Å .64); combination therapy less than no therapy (00.57 log; P Å .05); combination therapy count on seminal and blood plasma HIV-1 RNA levels. For / 9d3f$$fe38 12-05-97 11:32:37 jinfa UC: J Infect Figure 4 . Effect of reported nucleoside therapy on seminal and blood plasma HIV-1 RNA levels at study entry. A, HIV-1 RNA in seminal plasma for 117 subjects who reported receiving no therapy (n Å 73; 62.4%), monotherapy (n Å 30; 25.6%), or combination therapy (n Å 14; 12.0%). Median HIV-1 RNA copies/mL were 3.557, 2.945, and 2.786, respectively. B, HIV-1 RNA in blood for 124 subjects who reported receiving either no therapy (n Å 77; 62.1%), monotherapy (n Å 34; 27.4%), or combination therapy (n Å 13; 10.5%).
Median HIV-1 RNA copies/mL were 4.398, 4.584, and 4.398, respectively. Data are median and interquartile range; bars, 10th and 90th percentiles; l, outlying values; dotted line, lower limit of detection for each assay. For analysis, censored values were assigned HIV-1 RNA log copies/mL of 3.70 for branched-chain DNA (bDNA) and 2.30 for reverse transcription -polymerase chain reaction (RT-PCR) amplification -derived values.
seminal plasma (n Å 276 specimens with matched viral RNA HIV-1 RNA level variation obtained using data from all 338 pairs of seminal and blood plasma specimens. and CD4 values), antiretroviral therapy (after adjusting for CD4 count) was associated with a 0.49 log decline in RNA copies/ mL (P Å .04), and a 100-cell increase in blood CD4 cell count Discussion (after adjusting for therapy) was associated with a 0.16 log decline in viral RNA log copies/mL (P õ .001). After similar
We compared both qualitative and quantitative virologic measurements between the blood and genital compartments to adjustments for blood (n Å 282 specimens with matched values), antiretroviral therapy was associated with a 0.038 log address several controversial issues concerning HIV-1 shedding in semen and to obtain further information about the distridecline (P Å .68), and a 100 cell increase in CD4 cell count was associated with a 0.093 log decline in RNA copies/mL (P bution of virus between these two compartments. Evidence for viral compartmentalization was suggested by earlier studies õ .001). After adjusting for both antiretroviral therapy and CD4 cell count, the within-person variation in viral RNA log that noted the poor correlation between blood and seminal virus load, phenotype, and genotype [8, 10, 12, 29 -31] . We found copies/mL was 0.84 for seminal plasma and 0.25 for blood plasma. These numbers are consistent with the within-person further support for this viral compartmentalization based on / 9d3f$$fe38 12-05-97 11:32:37 jinfa UC: J Infect the following observations between semen and blood: lack of within the cell or cell-free compartments of the genital tract [7] . The mechanism for this discordance between viral RNA association between culturability of virus in semen and viral RNA level in blood, discordant distribution of viral phenotypes, levels and recovery of infectious virus by coculture requires further study. discordant viral RNA levels, a weak correlation between viral RNA level in semen and CD4 cell count in blood, differences
There was no apparent association between the SI or NSI viral phenotypes and seminal plasma HIV-1 RNA levels. This in the biologic variability of viral RNA levels, and differences in the virus load response to antiretroviral therapy.
complements the work of Vernazza et al. [10] and further supports the lack of association between the virus's MT-2 troCulturable virus in semen was strongly associated with the viral RNA level in semen. As such, the HIV-1 RNA level in pism and viral RNA levels reported for blood [40] , and the 27% discordance in phenotype between blood and semen offers the seminal plasma might be used to estimate potential infectiousness of semen. For example, men with persistently culturaadditional support for the compartmentalization of virus [12] .
Although there was a weak correlation between HIV-1 RNA ble HIV-1 in their semen had the highest seminal plasma virus levels, with a median of 1,023,000 (6.01 log) RNA copies/mL. levels in the blood plasma measured by the bDNA assay and HIV-1 RNA levels in the seminal plasma measured by the RTHowever, the broad range of HIV-1 RNA levels associated with the recovery of culturable virus from either the seminal PCR assay, neither the blood levels of HIV-1 RNA nor the CD4 cell count reliably predicted either shedding of culturable cell pellet or seminal plasma (or both) underscores the importance of other virologic and host factors that determine detecvirus or detection of viral RNA in semen. These observations fit with our earlier work as well as data from some, but not tion of virus by mixed lymphocyte coculture and, by inference, virus that is replicatively ''fit'' for sexual transmission [10] .
all, other reports [2, 15, 30, 41] . The clinical implication of these findings is that markers of systemic HIV infection, such In this regard, the male reproductive tract is similar to the blood compartment, in which higher HIV-1 RNA levels are as CD4 cell count or HIV-1 RNA level in the blood plasma, cannot be used alone to accurately predict HIV-1 RNA levels associated with increased rates of HIV-1 culture positivity in the blood plasma [32] and a greater risk for percutaneous transin the semen. As such, these findings support the current recommendations to use condoms for all sexual exposures despite mission [33] . However, unlike the situation in the blood compartment, the vast majority of infectious virus in semen is low viral RNA levels in either blood or semen. The discordance between very low seminal HIV-1 RNA levels and much higher associated with the cell pellet fraction and only rarely with the seminal plasma despite very high cell-free viral RNA levels.
blood plasma HIV-1 RNA levels in some men is further evidence for the virologic separation between the genital and blood Although we have no direct evidence regarding the influence of seminal HIV levels on sexual transmission, there is indirect compartments [7, 8, 42] . This discordance was not explained by differences between the two viral RNA assays used in our evidence to support such a relationship from studies correlating viral RNA levels in blood with the likelihood of sexual transstudy, given the high correlation between the RT-PCR and bDNA assays and the similar intraassay variabilities between mission [34, 35] .
Our study was hampered somewhat by the largely unknown blood and seminal plasma noted for RT-PCR [40, 43, 44 ]. There was a larger variation in seminal plasma HIV-1 RNA aspects of the biology of semen from HIV-infected men that affect the semen volume and the detection of both viral nucleic levels between men than there was within individual men. This finding offers an explanation for the lack of association between acid by RT-PCR amplification and infectious virus by coculture [29, 36 -38] . We found an inhibitor of the RT-PCR amplificathe number of unprotected sexual contacts and the probability of infection [45, 46] . However, even though HIV-1 RNA levels tion assay in the semen of 44% of men; this extends a similar observation by Dyer et al. [30] . Although the mechanism for in seminal plasma were relatively stable in individuals throughout the 2-month study period, there was 4-fold more variation this inhibition is unknown, semen contains a number of inhibitory antimicrobial compounds, such as exceptionally high levin the HIV-1 RNA levels in seminal plasma than in blood plasma. Therefore, for the individual man, multiple semen els of zinc, that specifically inhibit some viral enzymes [39] . Despite the use of silica gel to remove viral RNA from this specimens are required to obtain a reliable estimate of the seminal plasma RNA copy number. Longer-term studies are inhibition, viral RNA was not detected (at §400 RNA copies/ mL) in Ç20% of men studied. Importantly, the seminal plasma needed to determine if seminal plasma viral RNA levels are stable over many months, or perhaps years, in individual men inhibitor of the RT-PCR amplification assay did not appear to influence the detection of HIV by coculture. Therefore, the and the factors that influence these levels: for example, systemic illness, antiretroviral therapy, male genital tract inflamfailure to detect virus from the semen by coculture despite high levels of seminal plasma HIV-1 RNA in some men may mation, reactivation of genital herpes virus infections, and seminal shedding of cytomegalovirus or other viruses [2, 15, 41 , represent the presence of defective virus, effect of therapy on virus infectivity, insensitivity of the coculture assay, effect of 47 -51] . With these caveats, one potential implication of our study is that measuring the seminal plasma HIV-1 RNA level the genital tract immune response, semen-specific toxicity to or inhibition of either the virus or the mixed-lymphocyte coculmay prove useful in counseling couples (who wish to have children) about the likelihood of HIV-1 transmission to the ture (or both), or compartmentalization of infectious virus / 9d3f$$fe38
12-05-97 11:32:37 jinfa UC: J Infect female when the male is seropositive and the female is seronegThere were specific limitations to our study. First, our observational period of 2 months was short, and conclusions about ative.
Our data suggest that variation in virus load may be responthe relationship between HIV-1 RNA levels and infectiousness (culturability) cannot be generalized for longer time intervals. sible for the intermittent shedding of culturable HIV-1 from semen [2] . In our earlier studies, infectious virus was recovSecond, other than the direct measurement of culturable virus from the semen, we can only infer the impact of viral RNA ered from 11 (32%) of 34 men [5] , while another study reported recovery of virus in 10 (55%) of 18 men [10] . We have level on the potential for sexual transmission of HIV-1; furthermore, the insensitivity of coculture may have limited our power shown previously that concurrent cytomegalovirus shedding was associated with higher shedding rates of culturable HIVto detect associations between culturability, viral RNA levels, and our inferences about sexual transmissibility. Third, the 1 in semen, again suggesting that factors other than HIV-1 RNA level determine the presence of culturable HIV-1 in effect of antiretroviral therapy on virus levels in semen and blood at study entry was observational, relied on the self-resemen and, indirectly, the likelihood of HIV-1 sexual transmission [2, 34, 48, 52, 53] .
porting of therapy by the subjects, and clearly illustrates the need for prospective studies to address this important issue [14, This study has important implications for the design of clinical studies to evaluate new antiretroviral therapies. For men 60, 61].
In conclusion, there was only a weak correlation between with 3 semen samples taken before and again after therapy, only changes in HIV-1 RNA level of ú1.29 log (19-fold) could viral RNA levels in seminal and blood plasma. Viral RNA levels in seminal plasma were more variable than were those in be measured reliably over the short term; this contrasts with a 0.40-log (2.5-fold) change for blood plasma [54 -57] . Estimates blood plasma. Detection of culturable HIV in semen correlated strongly with the HIV-1 RNA levels in cell-free seminal plasma of sample sizes necessary to assess the effect of antiviral therapy on the seminal plasma HIV-1 RNA level could be deterbut only weakly with the blood plasma HIV-1 RNA level and CD4 cell count. These observations help resolve some immined by use of the person-to-person HIV-1 RNA variation and the within-person HIV-1 RNA variation. For example, portant controversies concerning HIV-1 shedding in semen, confirm the compartmentalization of HIV-1 between the blood in our sample-size calculations for a hypothetical two-arm, randomized study, a 5-fold-larger sample size was required to and the genital tract, and hold important implications for patient counseling and the design of clinical trials and epidemiologic demonstrate 0.7-log (5-fold) changes in HIV-1 RNA level in seminal plasma compared with blood plasma. Because the perstudies of HIV-1 sexual transmission. son-to-person variation was large relative to the within-person variation, taking more than 2 blood or semen samples per
